Alzheimer's Neuroimaging and Biomarker Initiative

Alzheimer's Disease Neuroimaging Initiative (ADNI4)

NIH-funded research Northern California Institute/res/edu · NIH-11386817

Collecting brain scans, blood, spinal fluid, and memory tests from people with and without memory problems to find markers that help detect and track Alzheimer's and improve trials.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNorthern California Institute/res/edu NIH-funded
Lab location1 site (San Francisco, United States)
Project IDNIH-11386817 on NIH RePORTER

What this research studies

If you join, researchers will collect MRI and PET brain scans, cognitive tests, blood samples, sometimes spinal (CSF) fluid, and genetic data and will follow you over time. Your de-identified data and samples are shared widely with other researchers to speed discoveries. ADNI4 focuses on using blood-based biomarkers and increasing enrollment of people from underrepresented communities so results apply to more people. Many participants are continuing from earlier ADNI phases and visits include both in-person testing and some remote follow-up.

Who could benefit from this research

Good fit: Older adults across the memory spectrum — people with normal cognition, subjective memory concerns, mild cognitive impairment, or Alzheimer's dementia — who are willing to undergo scans and give blood or CSF samples.

Not a fit: Participants should not expect direct treatment or symptom improvement from taking part, especially if they are seeking immediate therapeutic benefit or cannot tolerate imaging or lumbar puncture procedures.

Why it matters

Potential benefit: Could lead to earlier and more accurate detection of Alzheimer's and better-designed treatments for people in the future.

How similar studies have performed: Yes — prior ADNI phases produced thousands of publications, shaped clinical trial designs (including work used for aducanumab trials), and helped validate biomarkers used widely in Alzheimer's research.

Where this research is happening

San Francisco, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer disease prevention
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.